{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:11:32Z","timestamp":1765422692444},"reference-count":28,"publisher":"Japan Society for Clinical Immunology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2011]]},"DOI":"10.2177\/jsci.34.382","type":"journal-article","created":{"date-parts":[[2011,10,31]],"date-time":"2011-10-31T06:13:24Z","timestamp":1320041604000},"page":"382-387","source":"Crossref","is-referenced-by-count":5,"title":["Hyperimmunoglobulinemia D and periodic fever syndrome"],"prefix":"10.2177","volume":"34","author":[{"given":"Hidemasa","family":"SAKAI","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Shizuoka municipal hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"HEIKE","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Drenth JP et al. : Hyperimmunoglobulinemia D and periodic fever syndrome : the clinical spectrum in a series of 50 patients. <i>Medicine<\/i>, <b>73<\/b> : 133-144, 1994."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/9691"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1038\/9696"},{"key":"4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1212\/01.WNL.0000115390.33405.F7","volume":"62","author":"Simon A et al.","year":"2004","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.01.012"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-008-0130-4"},{"key":"7","unstructured":"7) Hilst JC et al. : Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. <i>Medicine<\/i>, <b>87<\/b> : 301-310, 2008."},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1002\/art.10550"},{"key":"9","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","volume":"54","author":"Mandey SH et al.","year":"2006","journal-title":"Arthritis Rheum","ISSN":"http:\/\/id.crossref.org\/issn\/0004-3591","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2008-03-144667","volume":"112","author":"Kuijk LM et al.","year":"2008","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"11","unstructured":"11) Kagami S et al. : Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cells. <i>Int Immunol<\/i>., <b>21<\/b> : 679-689, 2009."},{"key":"12","unstructured":"12) Zhang X et al. : Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. <i>J Immunol<\/i>. <b>180<\/b> : 6988-6996, 2008."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hager EJ et al. : Aberrant expression of costimulatory molecules in splenocytes of themevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS). <i>J Inherit Metab Dis<\/i>. 2011.","DOI":"10.1007\/s10545-011-9349-x"},{"key":"14","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2005-10-039578","volume":"109","author":"Bodar EJ et al.","year":"2007","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"15","unstructured":"15) Houten SM et al. : Temperture dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. <i>Hum. Molecular. Genetics<\/i>., <b>11<\/b> : 3115-3124, 2002."},{"key":"16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archderm.130.1.59","volume":"130","author":"Drenth JP et al.","year":"1994","journal-title":"Arch Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0003-987X","issn-type":"print"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem200"},{"issue":"3","key":"18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/bms.1200180305","volume":"18","year":"1989","journal-title":"Biomed Environ Mass Spectrom","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6134","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0009-8981(95)06162-2","volume":"243","author":"Siavoshian S et al.","year":"1995","journal-title":"Clinica Chimica Acta","ISSN":"http:\/\/id.crossref.org\/issn\/0009-8981","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1203\/PDR.0b013e3181761870","volume":"64","author":"Marcuzzi A et al.","year":"2008","journal-title":"Pediatr Res","ISSN":"http:\/\/id.crossref.org\/issn\/0031-3998","issn-type":"print"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.03.008"},{"issue":"1","key":"22","first-page":"87","volume":"25","author":"MARCUZZI ANNALISA","year":"2011","journal-title":"In Vivo","ISSN":"http:\/\/id.crossref.org\/issn\/0258-851X","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1203\/PDR.0b013e31821b581c","volume":"70","author":"Marcuzzi A et al.","year":"2011","journal-title":"Pediatr Res","ISSN":"http:\/\/id.crossref.org\/issn\/0031-3998","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kirschbaum MH et al. : A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia. <i>Leukemia<\/i>. 2011.","DOI":"10.1038\/leu.2011.124"},{"key":"25","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/rheumatology\/kem258","volume":"46","author":"Lequerr&eacute; T et al.","year":"2007","journal-title":"Rheumatology (Oxford)","ISSN":"http:\/\/id.crossref.org\/issn\/1462-0324","issn-type":"print"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0911-3"},{"key":"27","unstructured":"27) Korppi M et al. : Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report. <i>Acta Paediatr<\/i>. <b>100<\/b> : 21-25, 2011."},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070715"}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jsci\/34\/5\/34_5_382\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T11:59:58Z","timestamp":1621511998000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jsci\/34\/5\/34_5_382\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.34.382","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}